With the power to create nuclear fusion as well as breakthroughs in the medical field, engineers at Phoenix Nuclear Labs look to make a difference with their high power neutron accelerator.
Monona, WI – SHINE Medical Technologies, Inc., a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical tracers and cancer treatment elements, announced today that the staff of its primary regulator, the Nuclear Regulatory Commission (NRC), has completed their safety and environmental reviews and recommends approval of a Construction Permit for the SHINE facility.
SHINE is the first U.S. medical isotope producer to have reached this stage of the NRC permitting process since the 1960s.
Monona, WI – SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based medical isotope company, announced today that it has been awarded $1 million from the U.S. Department of Energy’s National Nuclear Security Administration (DOE/NNSA) as part of a $2 million cooperative agreement. The new funding will continue acceleration of SHINE’s efforts to establish a reliable, domestic supply of molybdenum-99 (moly-99) without weapons-usable highly enriched uranium.
Monona, WI and Aiken, SC – Savannah River Nuclear Solutions, LLC (SRNS), the management and operating contractor for the U.S. Department of Energy’s Savannah River National Laboratory (SRNL), has granted SHINE Medical Technologies, Inc. (SHINE) an exclusive license on SRNL’s patented hydrogen isotope separation process for use in medical isotope production. SHINE is a Wisconsin-based company founded to produce medical isotopes using its safe, cost-effective and environmentally-friendly technology. The agreement with SRNS gives SHINE the right to use SRNL’s thermal cycling absorption process (TCAP) in its manufacturing facility. The use of TCAP provides the high-purity inputs needed for SHINE’s patented…read more +
Originally Posted on The Badger Herald » News via UWIRE